Technology News and Research

RSS

Advantech Connect Online Partner Conference to Promote Edge-to-Cloud Partnerships and AIoT Solutions for Smart City Services

Irvine, California, April 21, 2021 - Advantech (stock code: 2395), a leading provider of advanced IoT intelligence systems, is excited to launch its Advantech Connect Online Partner Conference, an online partner conference for global partners, focusing on the theme “Edge-to-Cloud Partnerships Enable Smart City Services with AIoT”.

From Advantech 21 Apr 2021

Researchers explain how online symptom checkers generate probable diagnoses and suggestions

Have you recently turned to your mobile device or computer to find out if your cough, sniffle or fever could be caused by COVID-19?

21 Apr 2021

Fast oscillations in electroencephalography can pinpoint brain tissues responsible for epileptic seizures

Professor Bin He's team at Carnegie Mellon University, in collaboration with the Mayo Clinic, has discovered that fast oscillations in scalp-recorded electroencephalography can pinpoint brain tissues responsible for epileptic seizures.

21 Apr 2021

Asymmetric technique to synthesize aziridines in the presence of newly developed catalysts

Unless you've studied chemistry in college, it's unlikely you've come across the name aziridine. An organic compound with the molecular formula, C2H4NH, aziridines are well-known among medicinal chemists, who make use of the compound to prepare pharmaceutical drugs such as Mitomycin C, a chemotherapeutic agent known for its anti-tumor activity.

20 Apr 2021

Next-generation devices to test for ‘lazy eye’ in children developed using computer gaming technology

Computer gaming technology is being used to develop and pilot two low cost, next-generation screening tools for 'lazy eye' in children.

20 Apr 2021

Researchers develop new mathematical model to predict the onset of diseases

A myriad of genetic factors can influence the onset of diseases like high blood pressure, heart diseases, and type 2 diabetes.

20 Apr 2021

New nanomedicine device is effective for treating glioblastoma multiforme

A micro-sized polymeric net wrapping around brain tumors, just like a fishing net around a shoal of fish: this is the microMESH, a new nanomedicine device capable to conform around the surface of tumor masses and efficiently deliver drugs.

20 Apr 2021

New mathematical model could help design new probiotics and tailored diets to prevent diseases

A new mathematical model for the interaction of bacteria in the gut could help design new probiotics and specially tailored diets to prevent diseases. The research, from Chalmers University of Technology in Sweden, was recently published in the journal PNAS.

20 Apr 2021

New implantable tool images brain activity in 3D

Tools that allow neuroscientists to record and quantify functional activity within the living brain are in great demand. Traditionally, researchers have used techniques such as functional magnetic resonance imaging, but this method cannot record neural activity with high spatial resolution or in moving subjects.

20 Apr 2021

Yale scientists uncover common mechanism that promotes autoimmune diseases and blood cancers

In a study by Yale Cancer Center, researchers report on the discovery of a common mechanism that promotes both autoimmune diseases and blood cancers, including the blood diseases Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL).

19 Apr 2021

Building world’s first prototype to track moving tumors with real-time MRI during proton therapy

Researchers at the Helmholtz-Zentrum Dresden-Rossendorf want to build the world's first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton therapy.

19 Apr 2021

Researchers manufacture the SARS-CoV-2 RBD in pichia

Researchers in the United States and India have developed a high-volume, low-cost platform for manufacturing vaccines to protect against different variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

19 Apr 2021

MIPT and Harvard researchers grow and transplant retinal ganglion cells to treat glaucoma

A joint research carried out by MIPT scientists and Harvard researchers have presented retinal cells that can integrate into the retina.

19 Apr 2021

New COVID-19 vaccine could provide protection against existing and future strains of coronaviruses

A COVID-19 vaccine that could provide protection against existing and future strains of the COVID-19 coronavirus, and other coronaviruses, and cost about $1 a dose has shown promising results in early animal testing.

19 Apr 2021

Mirati to contribute $4 million grant to support SU2C research on KRAS mutant cancers

Stand Up To Cancer and Mirati Therapeutics Inc. - a late-stage targeted oncology company - today announced that Mirati will contribute a $4 million grant to SU2C to develop new approaches to treat patients with KRAS mutant cancers, as a part of the SU2C Catalyst program.

19 Apr 2021

Phico Therapeutics awarded up to $18.2 million USD (c.£13.2 million GBP) CARB-X funding to advance SASPject antibacterial therapy through Phase 1 clinical trials

Phico Therapeutics has been awarded a grant of up to $18.2 million USD to tackle the global rising threat of drug-resistant bacteria.

From Phico Therapeutics 19 Apr 2021

Study reveals new clues to sex differences in autism

It is well established that autism occurs much more frequently in boys than in girls, and that girls seem to have a greater resilience to developing the condition. It has been unclear, however, why that is.

19 Apr 2021

KHN’s ‘What the Health?’: Pause and effect on Covid vaccines

The effort to vaccinate Americans against covid-19 took a hit this week. The Centers for Disease Control and Prevention and the Food and Drug Administration jointly called for a pause in use of the vaccine made by Johnson & Johnson while experts try to figure out whether it is responsible for a small number of serious blood clots, mostly in women of childbearing age.

17 Apr 2021

Novel CRISPR-based technology may lead to powerful epigenetic therapies

Scientists have figured out how to modify CRISPR's basic architecture to extend its reach beyond the genome and into what's known as the epigenome -- proteins and small molecules that latch onto DNA and control when and where genes are switched on or off.

17 Apr 2021

Three teams selected to receive the first awards from Dartmouth Innovations Accelerator for Cancer

Three teams of Dartmouth researchers have been selected to receive the first awards from the Dartmouth Innovations Accelerator for Cancer.

17 Apr 2021

Technology News and Research

Advantech Connect Online Partner Conference to Promote Edge-to-Cloud Partnerships and AIoT Solutions for Smart City Services

Researchers explain how online symptom checkers generate probable diagnoses and suggestions

Fast oscillations in electroencephalography can pinpoint brain tissues responsible for epileptic seizures

Asymmetric technique to synthesize aziridines in the presence of newly developed catalysts

Next-generation devices to test for ‘lazy eye’ in children developed using computer gaming technology

Researchers develop new mathematical model to predict the onset of diseases

New nanomedicine device is effective for treating glioblastoma multiforme

New mathematical model could help design new probiotics and tailored diets to prevent diseases

New implantable tool images brain activity in 3D

Yale scientists uncover common mechanism that promotes autoimmune diseases and blood cancers

Building world’s first prototype to track moving tumors with real-time MRI during proton therapy

Researchers manufacture the SARS-CoV-2 RBD in pichia

MIPT and Harvard researchers grow and transplant retinal ganglion cells to treat glaucoma

New COVID-19 vaccine could provide protection against existing and future strains of coronaviruses

Mirati to contribute $4 million grant to support SU2C research on KRAS mutant cancers

Phico Therapeutics awarded up to $18.2 million USD (c.£13.2 million GBP) CARB-X funding to advance SASPject antibacterial therapy through Phase 1 clinical trials

Study reveals new clues to sex differences in autism

KHN’s ‘What the Health?’: Pause and effect on Covid vaccines

Novel CRISPR-based technology may lead to powerful epigenetic therapies

Three teams selected to receive the first awards from Dartmouth Innovations Accelerator for Cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News